Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and noteworthy falsehoods and distortions. With Trump back in the White House in 2025 ...
BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...
Up to $54.3 million CEPI investment aims to help advance Moderna’s H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...
An NIH scientist’s maverick approach reveals legal, ethical, moral, scientific and social challenges to developing potentially life-saving vaccines.
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...
The Chosun Ilbo on MSN
mRNA therapy rejuvenates immune cells in aged mice
Old mice experienced "rejuvenation" after receiving this injection. It is an injectable treatment utilizing ribonucleic acid, ...
The new study, published in the peer‑reviewed journal Drug Safety on December 11, suggested that shingles might occur after a ...
BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech's capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturingIn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback